An astonishingly large fraction of healthcare expenditures go toward heroic end-of-life treatments. I don’t know the exact percentage, but it’s big. What’s more, the benefit of such treatments is not terribly great; they typically extend one’s life by a few low-quality weeks or months. So why do people spend the money? Obviously, it’s hard for both dying people and their families to let go at the end. But just as important, the medical expenses are usually covered by health insurance or Medicare. When there’s a third-party buyer, there’s no reason to economize.
I’m not going to suggest that people should be forced to cover their end-of-life medical expenses out of pocket. It’s true that we use health insurance to cover lots of things that should be paid out of pocket, and would be if the tax code didn’t encourage employer-provided comprehensive health plans. But given the cost and risk associated with end-of-life treatments (your time of death is uncertain, as is the amount of money your pre-death treatment will involve), it’s sensible enough to insure for them. The problem is that once these expenses are insured, patients will consume medical treatment until the marginal benefit is zero or the insurance money runs out, whichever comes first.
So here’s my modest proposal. Health insurers (both private and public) should offer their customers a buy-out option: you can either incur the big end-of-life expenses, or you can accept a cash payment equal to some substantial fraction of the expected cost (say, 50%). Some people would still choose to take the heroic measures (and everyone would still have that option, at least among those who have it now), but others will take the cash in order to leave a larger inheritance, pay a grandchild’s tuition, take one last vacation, or throw an ass-kicking rock-your-face-off party. The insurers would be better off because they’ll pay out less than the expected cost of end-of-life treatment, and the patients will be better off, or at least no worse off, because they’ll have an option they didn’t have before.
Why aren’t insurers doing this already? The neoclassical economist in me says that if my plan were viable it would already have been implemented (at least by private insurers), so I must be missing something. The Austrian economist in me sees dollar bills on the sidewalk.
Tuesday, March 21, 2006
Subscribe to:
Post Comments (Atom)
3 comments:
Sounds like a great idea, provided I can use it to fund my cryonics coverage.
Yeah, the LTC/annuity combos are interesting, in that you cancel out two different kinds of adverse selection. Annuities appeal disproportionately to those who live long and prosper. LTC appeals disproportionately to those who will live long...hacking and wheezing. The combo splits the difference and provides a reason to buy the plan for both cohorts.
Unfortunately, the flip side of that coin is that it essentially guarantees a lapse rate of zero, so it's going to be pricy. And you had better be spot on in your mortality assumptions if you want to stay solvent. Should life expectancy suddenly and unexpectedly tick up the way it did in the 70s, forget it, you'd be wiped out.
But I don't really see that market going anywhere until many more of the regulators start letting companies treat LTC policies as having a cash value, and until Congress grants tax-free inside build up of that value. There are a few proposals to do just that, including one from Santorum, but with Chuck Grassley putting the kibosh even on expanding HSAs, I don't see it happening any time soon.
I second RiskyBiz's comment, Ray. It's nice to actually learn something from my commenters. I'm looking forward to anything you find out from talking to your contacts in the industry.
In addition to your possible explanations, I'd add a simple "ick factor" explanation. People might just rebel against the very thought of accepting a cash payment instead of doing (even pointless) treatment, and they might (unjustifiably) vilify the insurance firms for even offering such an option.
Post a Comment